The Monetary Authority of Singapore (MAS) has drawn a clear distinction between how different health insurance products handle rapid medical advancements. In a written parliamentary reply, Deputy Prime Minister and MAS Chairman Gan Kim Yong explained that while MediShield Life and Integrated Shield Plans (IPs) are regularly updated to include newer, less-invasive procedures, legacy Critical Illness (CI) policies operate under fixed definitions.

Updating these older CI contracts to include modern procedures without premium adjustments would threaten the actuarial sustainability of the products. According to the Monetary Authority of Singapore (MAS), the Life Insurance Association (LIA) is currently studying the feasibility of allowing policyholders to adjust existing coverage, though this remains a complex challenge. Consumers are being encouraged to take a more active role in assessing their insurance needs, as many may be unaware that their legacy policies might not trigger a payout for newer, more effective treatments that fall outside old definitions.

Southeast Asia Healthcare Marketing: 365Asia Expert Perspective

This gap between medical progress and insurance wording is a significant pain point for long-term policyholders. For financial advisers, this is an opportunity to prove your value by conducting deep audits of legacy policies that your clients may have forgotten. The risk of a claim being rejected due to outdated terminology is real, and the regulator’s advice for consumers to seek financial advice has never been more relevant. We suggest using a specialised adviser framework to help your clients transition into more flexible, modern CI plans. If you are looking for ways to educate your client base on the importance of these reviews, contact us to see how our educational content strategies can help you build a stronger, more informed client relationship.